Is Anyone Worried?

Am I the only one that’s concerned about the advent of new innovations in PE? It seems odd that more and more PE firms are utilizing continuation fund strategies to “extend” the timeline of an investment and buying the debt of its own portfolio companies. It seems disingenuous to say the least, but it’s marketed as these great innovations for LPs. 

 

I think of it less as an innovation and more of a sign of where the markets are at. Continuation vehicles aren't really a new concept. CVs are just a legal mechanism for funds to realize economics, while still holding onto an asset. At the right terms, they can be very advantageous for GPs economically

 

That’s exactly the problem. GPs are acting in their own interests to crystallize gains on an asset by selling to themselves and marketing continuation vehicles to secondary investors that may or may not have been sold in the primary markets (i.e., other sponsors or strategies). It’s just odd that they keep raising funds that are then used to trade assets around like hot potatoes while ultimately the LPs (e.g., pensions funds, endowments, etc.) and portfolio companies suffer with the constant relieveraging of its balance sheets. 

 
Most Helpful

as someone who works in secondaries, i feel the way that it is portrayed in the media as the gp "selling to themselves" is a bit misleading. Yes, they still control the company, but the price is set by the secondary buyer*. And the selling LPs have a choice whether to participate or not. It's not some scam where the GP decides the price and LPs are forced to live with it (i.e. the GP can't just say the secondary buyers will buy the asset(s) for $0). 

In contrast, when a GP sells a minority stake (often to another GP), the LPs are "forced" to sell their pro-rata at that valuation. With a gp-led, at least they can choose to maintain their pro-rata if they don't like the valuation.

*I'm sure someone will mention that in some GP-leds, the secondary buyers are not able to set the price themselves in the sense where they could say "we will pay x", but rather the deal is presented to them on a take-it-or-leave-it basis (e.g. basically all clearlake GP-leds). The secondary buyer still has the option to reject participating in that deal if they think the deal isn't fair and if the market deems it not a fair price, then the deal won't get done, so i still view this as price discovery. 

 

Do you think the secondaries investors can make money from these CVs?

 

yes, generally these are great setups. Rather than a new sponsor getting to capture the remaining upside in an asset (i.e. a sponsor to sponsor trade), the current GP can continue to execute their business plan going forward by getting new LPs and allowing them (the GP) to continue owning the asset.

The risk factor is also much lower since the GP should have a good sense already of everything going on at the company whereas a new owner will need time to implement their changes and discover any bones in the closet. this is not to say some GP-leds won't blow up, of course they will, but that's no different than any other investment. There is always risk. 

 

How would a CV work for existing management at a PortCo? Say they have hurdles in place for equity to vest and the original sponsor decides to extend their investment timeline, would management RSUs/ownership vest upon the transaction assuming hurdles are met? I know the COO of a sponsor owned company with millions in ownership, but the PortCo is approaching 5 years held now. Wondering where this will lead.

 

It honestly seems like a bunch of baloney. Seems like LPs get screwed and GPs get to collect more fees

 

From my understanding not true lol. LPs get the opportunity to cash out, but they also have the opportunity to roll into the secondary vehicle which will have mitigated j curve, higher IRR, better performance than putting money into a brand new PE fund. Win win: LPs can either choose liquidity or statistically better returns

 

You’re just regurgitating what the GPs typically tell LPs when they do continuation funds. Yes, the incremental returns may be compelling for a few cases where you have an A or A+ asset in your hands and there is continued opportunity for value creation, but that certainly does not apply for the majority of deals that are happening. Continuation funds have exploded over the past 3-4 years and it seems hard to believe there are enough “quality” assets to fuel the supply of secondary funds that are being raised. 

The counter argument is that GPs are using continuation funds to extend the timeline they need to “fix” the asset. The secondary investors can “choose” to invest or not, but from my perspective, it’s never the style of diligence that another primary sponsor would do and that’s one of the issues. If one of the blue chip sponsors is doing a continuation fund for one of their assets, secondary investors typically do less diligence and invest within a constrained period of time. It’s like the 2020-2021 timeframe when all the VCs would forgo diligence as another blue chip VC was leading the round. 

I do think continuation funds have a role to play in the capital markets, but from my perspective, the pendulum has swung too far in one direction with too much capital being raised in the space. It’s just another asset gathering strategy and these things never have a good ending. 

 

We (a GP) are looking at CVs as an opportunity more than a necessity. We have a few assets that have been growing like crazy and have strong macro tailwinds that are already several years in but that we’d love to hold for another 5+ years. The prospect of crystallizing current economics and then continuing to compound for another round is pretty compelling, and it’s less risky than buying a new asset because you already know what’s going on under the hood (although there are new risks that get introduced)

I can definitely see how you could try to spin that same story for a shitshow platform that you couldn’t sell, but as mentioned above the “market” will still agree on the price, and you need to sell both current and new LPs on it. 
 

Selfishly though, as a newer VP I’d spend my time on a new deal that I have full economics in rather than compounding something the firm bought when I was an analyst lol

 

I agree, it seems quite convenient and frankly suspicious that CVs are being approached as an "opportunity" vs. "necessity" in a time like today where multiples are compressed compared to last 2 years and liquidity is tight AF where hardly anyone can get a loan from the bank to do a deal. Even if they can get debt, it's pretty hard to be making the same returns today on 7%+ debt (assuming SOFR + 375 while SOFR currently >4%) eating into your IRR and no one wants to sell their investments at a loss which they bought in the last 2 years. It seems awfully convenient to just avoid taking the "L" and pushing it into a new fund and forcing new LPs to buy into it. Even though yes the GP often does get a fairness opinion from an investment bank, we all know that fairness opinions are bought and are not pure third party valuation opinions. The Ibank just wants the GP's fee and will value it wherever the GP wants it valued to transact at. 

 

As someone that worked on these fairness opinion at a bank, that’s as reliable as the private equity marks on their own portfolio. People have just accepted this as a matter of fact, but it’s shocking to never hear any pushback.

 

But again, this misrepresents what is happening.

First of all, you need to find a willing buyer. The GP can't force the secondary buyers to buy it. and the existing LPs are given the choice whether to sell or not. 

2nd, everyone knows that fairness opinions are a joke, in all transactions. But this isn't specific to GP-leds, this is the same deal with vanilla M&A, restructuring, etc. 

3rd, GP-leds are not centered around new assets that are underpforming. It would be hard to find a buyer. Are there underpforming assets in some deals? Of course, but often it's part of a multi-asset deal, and again you still need to find a willing buyer, 

 

I think you misinterpreted my note on forcing LPs to buy in. Yes nobody’s forcing the LPs to buy in, but what I’m saying is the GP’s sort of are forcing them by saying “If you want to invest into our newly vintages Fund X targeting $20 bn, then part of the deal is you’re buying into this $1.5 bn asset we’re purchasing from another fund which we also refuse to mark down nor run a real process on. Also we’ll only give you very limited info on the asset itself in a VDR and you don’t get to run a due diligence on it or talk to management.”

It’s like making the LPs eat a little bit of shit for a chance at a bigger piece of the pie. These are not coinvestment deals, it’s either buy into the new fund at these terms or don’t buy in at all.

 

It seems odd you aren’t legally required to run a full process for the asset in these scenarios to get a better sense of price discovery / meet fiduciary obligations to LPs.

An interesting recent deal is Brookfield’s transaction of Westinghouse, where Brookfield sold the asset to another division of itself, but ran a competitive bidding process with non-Brookfield sponsors

 

Eos ut impedit illo itaque voluptatem quia non sit. Saepe voluptatem vel aut eum quae temporibus. Provident ipsam repellat ipsa fugit aut. Expedita dolores beatae officia nostrum. Qui harum atque nobis exercitationem.

Voluptate excepturi architecto magni et consequatur sunt aut laborum. Nisi in vitae ad nulla autem earum. Voluptatem neque delectus enim quisquam repellat facilis. Nihil sapiente quis aut excepturi rerum est aut earum. Sed id hic qui est labore aut.

 

Harum qui sit quo sint aut placeat. Aut voluptatem explicabo aut voluptatum. Nihil quasi est illum quia molestias.

Ut iusto quae nostrum similique voluptatum laborum sequi. Eos aperiam ipsa cupiditate. Eius corrupti reiciendis rerum labore vel unde. Sint fugit nostrum velit quis vel fugit dolor. Iusto optio harum sit nostrum in est soluta. Consequuntur ipsum odio sit eos repellendus id repudiandae. Aut voluptas dolores in facilis qui sunt ut.

Sunt et dolores earum quis quisquam sed quos. Fugit iusto molestiae quis nobis totam placeat dicta. Tenetur voluptas provident aut iste.

Career Advancement Opportunities

May 2024 Private Equity

  • The Riverside Company 99.5%
  • Blackstone Group 99.0%
  • Warburg Pincus 98.4%
  • KKR (Kohlberg Kravis Roberts) 97.9%
  • Bain Capital 97.4%

Overall Employee Satisfaction

May 2024 Private Equity

  • The Riverside Company 99.5%
  • Blackstone Group 98.9%
  • KKR (Kohlberg Kravis Roberts) 98.4%
  • Ardian 97.9%
  • Bain Capital 97.4%

Professional Growth Opportunities

May 2024 Private Equity

  • The Riverside Company 99.5%
  • Bain Capital 99.0%
  • Blackstone Group 98.4%
  • Warburg Pincus 97.9%
  • Starwood Capital Group 97.4%

Total Avg Compensation

May 2024 Private Equity

  • Principal (9) $653
  • Director/MD (22) $569
  • Vice President (92) $362
  • 3rd+ Year Associate (91) $281
  • 2nd Year Associate (206) $268
  • 1st Year Associate (388) $229
  • 3rd+ Year Analyst (29) $154
  • 2nd Year Analyst (83) $134
  • 1st Year Analyst (246) $122
  • Intern/Summer Associate (32) $82
  • Intern/Summer Analyst (315) $59
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
Betsy Massar's picture
Betsy Massar
99.0
4
Secyh62's picture
Secyh62
99.0
5
dosk17's picture
dosk17
98.9
6
kanon's picture
kanon
98.9
7
CompBanker's picture
CompBanker
98.9
8
GameTheory's picture
GameTheory
98.9
9
numi's picture
numi
98.8
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”